Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening

Abstract Background Leishmaniasis is a disease caused by protozoan forms called Leishmania which infect animals and humans. The drugs have been in use since half a century due to which there have been mutations in the microbe-facilitating drug resistance. So this provides a reason for searching for...

Full description

Saved in:
Bibliographic Details
Main Authors: Deepak A. Yaraguppi (Author), Sanjay H. Deshpande (Author), Zabin K. Bagewadi (Author), Uday Muddapur (Author), Sushil Anand (Author), Santosh B. Patil (Author)
Format: Book
Published: SpringerOpen, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ae9588c1f8248e687d2d13c4fd88a8b
042 |a dc 
100 1 0 |a Deepak A. Yaraguppi  |e author 
700 1 0 |a Sanjay H. Deshpande  |e author 
700 1 0 |a Zabin K. Bagewadi  |e author 
700 1 0 |a Uday Muddapur  |e author 
700 1 0 |a Sushil Anand  |e author 
700 1 0 |a Santosh B. Patil  |e author 
245 0 0 |a Identification of potent natural compounds in targeting Leishmania major CYP51 and GP63 proteins using a high-throughput computationally enhanced screening 
260 |b SpringerOpen,   |c 2020-06-01T00:00:00Z. 
500 |a 10.1186/s43094-020-00038-w 
500 |a 2314-7253 
520 |a Abstract Background Leishmaniasis is a disease caused by protozoan forms called Leishmania which infect animals and humans. The drugs have been in use since half a century due to which there have been mutations in the microbe-facilitating drug resistance. So this provides a reason for searching for effective drugs for the disease. In the current work, an effort has been to find such drugs that act on disease-relevant receptors by similarity indexing method, molecular docking, and dynamics studies. The study focused on the rapid expansion of potential anti-leishmanial compounds that could function as novel natural compound structures for future drug Results Similarity indexing of existing drugs with natural compounds using Tanimoto clustering resulted in 4 compounds with similarity index of greater than 0.7 (70% similarity). The molecular docking of the resulted compounds was carried out with therapeutic targets CYP51 and GP63 proteins. N-methyltyrosyl-N-methyltyrosyl-leucyl-alanine from Streptomyces griseus showed higher binding affinity in comparison to inhibitor and other selected natural compounds. Simulation studies revealed that the binding configuration of the compound with targets was highly stable all through 10 ns of simulation time with intact hydrogen bonding. Conclusions The molecular docking and molecular dynamics studies for the selected natural bioactive compound N-methyltyrosyl-N-methyltyrosyl-leucyl-alanine from Streptomyces griseus showed better binding affinity with the selected therapeutics targets and can be further considered for in vitro and in vivo studies which may lead to a possible new drug for the treatment of Leishmaniasis. 
546 |a EN 
690 |a Leishmaniasis 
690 |a Similarity indexing 
690 |a Molecular docking 
690 |a Drug design 
690 |a Natural compounds 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Future Journal of Pharmaceutical Sciences, Vol 6, Iss 1, Pp 1-10 (2020) 
787 0 |n http://link.springer.com/article/10.1186/s43094-020-00038-w 
787 0 |n https://doaj.org/toc/2314-7253 
856 4 1 |u https://doaj.org/article/8ae9588c1f8248e687d2d13c4fd88a8b  |z Connect to this object online.